A model prediction of long-term prognosis in patients with centrally located hepatocellular carcinoma undergoing hepatectomy

Wu, 1999, Mesohepatectomy for centrally located hepatocellular carcinoma: an appraisal of a rare procedure, J Am Coll Surg, 188, 508, 10.1016/S1072-7515(99)00026-5 Scudamore, 2000, Mesohepatectomy, Am J Surg, 179, 356, 10.1016/S0002-9610(00)00374-3 Poon, 2002, Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified?, Ann Surg, 236, 602, 10.1097/00000658-200211000-00010 Hu, 2003, Treatment of centrally located hepatocellular carcinoma with central hepatectomy, surgery, 133, 251, 10.1067/msy.2003.102 Lang, 2004, Mesohepatectomy-an alternative to extended hepatectomy in the treatment of central liver tumors, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen., 75, 424, 10.1007/s00104-003-0803-7 Chen, 2007, Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma, Dig Surg, 24, 208, 10.1159/000102901 Ishii, 2013, Mesohepatectomy with total caudate lobectomy of the liver for hepatocellular carcinoma, World J Surg Oncol, 11, 82, 10.1186/1477-7819-11-82 Qiu, 2013, Mesohepatectomy for centrally located liver tumours, Br J Surg, 100, 1620, 10.1002/bjs.9286 Lee, 2014, Central hepatectomy for centrally located malignant liver tumors: a systematic review, World J Hepatol, 6, 347, 10.4254/wjh.v6.i5.347 Yang, 2014, Mesohepatectomy for centrally located large hepatocellular carcinoma: indications, techniques, and outcomes, surgery, 156, 1177, 10.1016/j.surg.2014.05.012 Zuo, 2014, Mesohepatectomy for the treatment of patients with centrally located hepatocellular carcinoma, Mol Clin Oncol, 2, 833, 10.3892/mco.2014.309 Lee, 2015, Central hepatectomy versus extended hepatectomy for liver malignancy: a matched cohort comparison, HPB - Off J Int Hepato Pancreato Biliary Assoc, 17, 1025, 10.1111/hpb.12507 Qiu, 2016, The prognostic value of a classification system for centrally located liver tumors in the setting of hepatocellular carcinoma after mesohepatectomy, Surg Oncol, 25, 441, 10.1016/j.suronc.2016.03.001 Chen, 2014, Mesohepatectomy versus extended hemihepatectomy for centrally located hepatocellular carcinoma, Hepatobiliary Pancreat Dis Int - HBPD INT, 13, 264, 10.1016/S1499-3872(14)60253-8 Li, 2018, Anatomic mesohepatectomy versus extended hepatectomy for patients with centrally located hepatocellular carcinoma, HPB - Off J Int Hepato Pancreato Biliary Assoc, 20, 530, 10.1016/j.hpb.2017.11.012 Johnson, 2015, Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade, J Clin Oncol - Off J Am Soc Clin Oncol, 33, 550, 10.1200/JCO.2014.57.9151 Hiraoka, 2017, Validation and potential of albumin-bilirubin grade and prognostication in a nationwide survey of 46,681 hepatocellular carcinoma patients in Japan: the need for a more detailed evaluation of hepatic function, Liver cancer, 6, 325, 10.1159/000479984 Michitaka, 2016, Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade, Hepatol Res - Off J Japan Soc Hepatol, 114, 744 Cheng, 2012, Surgical resection of centrally located large hepatocellular carcinoma, Chang Gung Med J, 35, 178 Gallagher, 2013, Outcomes of central bisectionectomy for hepatocellular carcinoma, HPB - Off J Int Hepato Pancreato Biliary Assoc, 15, 529, 10.1111/j.1477-2574.2012.00615.x Addissie, 2015, Classification and staging of hepatocellular carcinoma: an aid to clinical decision-making, Clin Liver Dis, 19, 277, 10.1016/j.cld.2015.01.011 Yamakado, 2015, Sub-classification of intermediate-stage (barcelona clinic liver cancer stage-B) hepatocellular carcinomas, World J Gastroenterol, 21, 10604, 10.3748/wjg.v21.i37.10604 Yamakado, 2014, Treatment strategies of intermediate-stage hepatocellular carcinomas in Japan (Barcelona Clinic Liver Cancer stage B), Oncology, 87, 78, 10.1159/000368149 Eguchi, 2010, Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection, World J Surg, 34, 1034, 10.1007/s00268-010-0424-5 Jonas, 2001, Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis, Hepatology (Baltimore, Md.)., 33, 1080, 10.1053/jhep.2001.23561 Lim, 2011, Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria, Ann Surg, 254, 108, 10.1097/SLA.0b013e31821ad884 Lee, 2017, Survival analysis after liver resection for hepatocellular carcinoma: a consecutive cohort of 1002 patients, J Gastroenterol Hepatol, 32, 1055, 10.1111/jgh.13632 Makuuchi, 2010, Mini-mesohepatectomy for colorectal metastasis invading the middle hepatic vein at the hepatocaval confluence: educational video demonstrating IOUS use in modern hepatic surgery, Ann Surg Oncol, 17, 356, 10.1245/s10434-009-0826-5 Donadon, 2011, From mesohepatectomy to mini-mesohepatectomy: evolving the concept of resectability of hepatic tumors at the hepatocaval confluence, Dig Surg, 28, 109, 10.1159/000323819 Chen, 2017, Central hepatectomy still plays an important role in treatment of early-stage centrally located hepatocellular carcinoma, World J Surg, 41, 2830, 10.1007/s00268-017-4096-2 Stratopoulos, 2007, Central hepatectomy: the golden mean for treating central liver tumors?, Surg Oncol, 16, 99, 10.1016/j.suronc.2007.05.002 Sohn, 2014, HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma, Ann Surg Oncol, 21, 2429, 10.1245/s10434-014-3621-x Huang, 2013, Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels, Ann Surg, 257, 490, 10.1097/SLA.0b013e318262b218 Huang, 2015, Antiviral therapy improves postoperative survival in patients with hepatocellular carcinoma: a randomized controlled trial, Ann Surg, 261, 56, 10.1097/SLA.0000000000000858 Huang, 2018, Antiviral therapy reduces hepatocellular carcinoma recurrence in patients with low HBV-DNA levels: a randomized controlled trial, Ann Surg, 10.1097/SLA.0000000000002727 Wu, 2009, Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma, J Hepatol, 51, 890, 10.1016/j.jhep.2009.07.009 Hosaka, 2013, Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection, Hepatology (Baltimore, Md.)., 58, 98, 10.1002/hep.26180 Yang, 2012, TGF-beta-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma, Cancer cell, 22, 291, 10.1016/j.ccr.2012.07.023